sisi li

Pediatric · Clinical medicine

Author

APID: 4973
ORCID: 0000-0002-4862-8740
Google Scholar: https://scholar.google.com/citations?user=khxc-e0AAAAJ&hl=en
Location: Hangzhou, Zhejiang, China
Expertise: Hematology/Oncology，Immunotherapy for Malignant Tumors
Areas of interest: Hematology/Oncology，Immunotherapy for Malignant Tumors，Dynamic Immune Equilibrium in the Organism
Member since: November 2023

Biography

Dr. Li earned her doctoral degree in medicine in 2011 and has since devoted her career to foundational and scientific research in hematopoietic system diseases. Her research primarily focuses on unraveling the molecular biology mechanisms and pioneering immunotherapies for hematologic malignancies, with the aim of enhancing the prognosis of cancer patients through innovative treatment modalities like antibody-targeted therapy and cellular immunotherapy. Simultaneously, she delves into studying the immune system's response to infections and immune regulation. Principal investigator for 4 national and provincial-level projects, involved in more than 10 major scientific and technological plans and national projects. Published over 30 papers as a co-author. Holds 2 granted invention patents. Serves as a reviewer for journals such as the Journal of Drug Targeting, Journal of Pediatrics Research Reviews & Reports, and Journal of Clinical Case Studies Reviews & Reports.